Targeting mutant p53 for cancer therapy: direct and indirect strategies

J Hu, J Cao, W Topatana, S Juengpanich, S Li… - Journal of hematology & …, 2021 - Springer
TP53 is a critical tumor-suppressor gene that is mutated in more than half of all human
cancers. Mutations in TP53 not only impair its antitumor activity, but also confer mutant p53 …

Mutational drivers of cancer cell migration and invasion

NM Novikov, SY Zolotaryova, AM Gautreau… - British journal of …, 2021 - nature.com
Genomic instability and mutations underlie the hallmarks of cancer—genetic alterations
determine cancer cell fate by affecting cell proliferation, apoptosis and immune response …

Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth

J Zhu, MA Sammons, G Donahue, Z Dou, M Vedadi… - Nature, 2015 - nature.com
TP53 (which encodes p53 protein) is the most frequently mutated gene among all human
cancers. Prevalent p53 missense mutations abrogate its tumour suppressive function and …

Gain-of-function mutant p53: all the roads lead to tumorigenesis

Y Stein, V Rotter, R Aloni-Grinstein - International journal of molecular …, 2019 - mdpi.com
The p53 protein is mutated in about 50% of human cancers. Aside from losing the tumor-
suppressive functions of the wild-type form, mutant p53 proteins often acquire inherent …

Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer

E Chirshev, KC Oberg, YJ Ioffe… - Clinical and translational …, 2019 - Springer
Abnormal regulation and expression of microRNAs (miRNAs) has been documented in
various diseases including cancer. The miRNA let-7 (MIRLET7) family controls …

Mutant p53 on the path to metastasis

Q Tang, Z Su, W Gu, AK Rustgi - Trends in cancer, 2020 - cell.com
Metastasis contributes to the vast majority of cancer-related mortality. Regulatory
mechanisms of the multistep invasion-metastasis cascade are being unraveled. TP53 is the …

Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer

D Walerych, K Lisek, R Sommaggio, S Piazza… - Nature cell …, 2016 - nature.com
In cancer, the tumour suppressor gene TP53 undergoes frequent missense mutations that
endow mutant p53 proteins with oncogenic properties. Until now, a universal mutant p53 …

A step-by-step microRNA guide to cancer development and metastasis

GS Markopoulos, E Roupakia, M Tokamani… - Cellular Oncology, 2017 - Springer
Background Cancer is one of the leading causes of mortality. The neoplastic transformation
of normal cells to cancer cells is caused by a progressive accumulation of genetic and …

Targeting the oncogenic p53 mutants in colorectal cancer and other solid tumors

H Li, J Zhang, JHM Tong, AWH Chan, J Yu… - International journal of …, 2019 - mdpi.com
Colorectal cancer (CRC) is a kind of solid tumor and the third most common cancer type in
the world. It is a heterogeneous disease characterized by genetic and epigenetic …

RBMMMDA: predicting multiple types of disease-microRNA associations

X Chen, C Clarence Yan, X Zhang, Z Li, L Deng… - Scientific reports, 2015 - nature.com
Accumulating evidences have shown that plenty of miRNAs play fundamental and important
roles in various biological processes and the deregulations of miRNAs are associated with a …